Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Sclerostin anticorps

SOST Reactivité: Humain IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7264263
  • Antigène Voir toutes Sclerostin (SOST) Anticorps
    Sclerostin (SOST)
    Reactivité
    • 64
    • 52
    • 35
    • 16
    • 15
    • 15
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 66
    • 3
    • 2
    • 1
    Lapin
    Clonalité
    • 67
    • 5
    Polyclonal
    Conjugué
    • 29
    • 6
    • 6
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Cet anticorp Sclerostin est non-conjugé
    Application
    • 70
    • 30
    • 24
    • 22
    • 13
    • 12
    • 5
    • 4
    • 3
    • 2
    • 2
    Immunohistochemistry (IHC)
    Attributs du produit
    Polyclonal Antibody
    Purification
    Affinity purification
    Immunogène
    Recombinant fusion protein of human SOST (NP_079513.1).
    Isotype
    IgG
    Top Product
    Discover our top product SOST Anticorps primaire
  • Indications d'application
    IHC 1:50-1:100
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 mg/mL
    Buffer
    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. Avoid freeze / thaw cycles.
  • Antigène
    Sclerostin (SOST)
    Autre désignation
    SOST (SOST Produits)
    Synonymes
    anticorps LOC100313724, anticorps CDD, anticorps VBCH, anticorps 5430411E23Rik, anticorps sclerostin, anticorps LOC100313724, anticorps SOST, anticorps Sost
    Sujet
    Sclerostin is a secreted glycoprotein with a C-terminal cysteine knot-like (CTCK) domain and sequence similarity to the DAN (differential screening-selected gene aberrative in neuroblastoma) family of bone morphogenetic protein (BMP) antagonists. Loss-of-function mutations in this gene are associated with an autosomal-recessive disorder, sclerosteosis, which causes progressive bone overgrowth. A deletion downstream of this gene, which causes reduced sclerostin expression, is associated with a milder form of the disorder called van Buchem disease.
    ID gène
    50964
    UniProt
    Q9BQB4
Vous êtes ici:
Support technique